Skip to content

Efficacy of Asgand in women with decrease fertility due to anovulation.

Efficacy of Asgand in women with anovulatory subfertility : A Randomised, Single blind placebo control trial. - EAS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113610
Enrollment
100
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

Intervention1: Asgand powder: 7gm Asgand powder orally with milk twice a day for 3 months. Control Intervention1: Placebo: Gram roasted flour in powdered form 7gm twice a day orally for 3 months.

Sponsors

Department of Niswan wa Qabalat Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married women who have been diagnosed with anovulatory infertility. Willing to participate and signed informed consent.

Exclusion criteria

Exclusion criteria: Secondary infertility due to any surgical intervention. Patients having received hormone treatment in the past 3 month. Patients having any serious systemic illness. Patients allergic to experimental drug.

Design outcomes

Primary

MeasureTime frame
Ovulation on Follicular study/increase in Antral Follicle Count. Increase in AMH. Timepoint: Assessment of all parameters at initiation of study then at completion of study for 3 months.

Secondary

MeasureTime frame
ConceptionTimepoint: During period of 3 months intervention.

Countries

India

Contacts

Public ContactDr Abiha Ahmad Khan

Ajmal Khan Tibbiya College and Hospital

abihaahmad89@gmail.com9620551870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026